{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.1157",
  "meta": {
    "versionId": "7",
    "lastUpdated": "2022-03-02T18:02:37.000-05:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1157",
  "version": "20211102",
  "name": "Substance Use Disorder Short Acting Medication Administration",
  "status": "active",
  "date": "2022-03-03T18:46:01-05:00",
  "publisher": "NCQA PHEMUR",
  "compose": {
    "include": [
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1152"
        ]
      },
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1155"
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:e0fc3b9a-d078-4775-a99e-aed3a524d7d1",
    "timestamp": "2022-06-10T12:17:50-04:00",
    "total": 7,
    "offset": 0,
    "parameter": [
      {
        "name": "count",
        "valueInteger": 1000
      },
      {
        "name": "offset",
        "valueInteger": 0
      }
    ],
    "contains": [
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20220301",
        "code": "310653000",
        "display": "Drug addiction therapy using methadone (regime/therapy)"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version": "2022",
        "code": "G2067",
        "display": "Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version": "2022",
        "code": "G2068",
        "display": "Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version": "2022",
        "code": "G2078",
        "display": "Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version": "2022",
        "code": "G2079",
        "display": "Take-home supply of buprenorphine (oral); up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version": "2022",
        "code": "H0020",
        "display": "Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program)"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version": "2022",
        "code": "H0033",
        "display": "Oral medication administration, direct observation"
      }
    ]
  }
}